"intensive; immunoparalysis; immunostimulation; MODS; sepsis; cytomegalovirus; outcome"@en . "http://www.isvav.cz/projectDetail.do?rowId=NR7777"^^ . "0"^^ . " immunoparalysis" . . . "NR7777" . "Immodin to influence immunoparalysis, MODS and sepsis course in long term ICU patients"@en . . . "Hypothesis is tested that imunostimulatory drug Immodin reverses immunoparalysis in critically ill patients requiring long term intensive care. Hypothesis is tested that reversal of immunoparalysis will positively influence the course of multiorgan dysfunction syndrome and sepsis in long term ICU patients. Hypothesis is tested that reversal of immunoparalysis will positively influence the course of multiorgan dysfunction syndrome and sepsis in long term ICU patients."@en . . " cytomegalovirus" . . . . . . . " immunostimulation" . . " sepsis" . "intensive" . . "2007-08-08+02:00"^^ . "Immodin does not influence outcome, ICU stay, nosocomial infection, sepsis and SIRS, MODS, immunologic and inflammatory markers in critically ill with immunoparalysis. Monocyte activation (CD14+HLADR+) does not predict ICU mortality."@en . . "Je testov\u00E1na hypot\u00E9za, \u017Ee pod\u00E1v\u00E1n\u00EDm imunostimulans Immodinu obnov\u00EDme reaktivitu imunitn\u00EDho syst\u00E9mu u kriticky nemocn\u00FDch vy\u017Eaduj\u00EDc\u00EDch dlouhodobou intenzivn\u00ED p\u00E9\u010Di. Je testov\u00E1na hypot\u00E9za, \u017Ee navozen\u00ED imunoreaktivity povede k p\u0159\u00EDzniv\u00E9mu v\u00FDvoji multiorg\u00E1nov\u00E9ho selh\u00E1v\u00E1n\u00ED a sepse u kriticky nemocn\u00FDch vy\u017Eaduj\u00EDc\u00EDch dlouhodobou intenzivn\u00ED p\u00E9\u010Di." . . "Immodin k ovlivn\u011Bn\u00ED pr\u016Fb\u011Bhu imunoparal\u00FDzy, multiorg\u00E1nov\u00E9ho selh\u00E1v\u00E1n\u00ED (MODS) a sepse a u kriticky nemocn\u00FDch vy\u017Eaduj\u00EDc\u00EDch dlouhodobou intenzivn\u00ED p\u00E9\u010Di" . "3"^^ . "0"^^ . "3"^^ . . "Immodin neovliv\u0148uj\u011B mortalitu, d\u00E9lku hospitalizace, v\u00FDskyt nozokomi\u00E1ln\u00EDch infekc\u00ED, sepse a SIRS, pr\u016Fb\u011Bh MODS, imunologick\u00E9 a z\u00E1n\u011Btliv\u00E9 parametry u kriticky nemocn\u00FDch s imunoparal\u00FDzou. Aktivace monocyt\u016F (CD14+HLADR+) v prvn\u00EDch dnech nep\u0159edv\u00EDd\u00E1 mortalitu."@cs . "1"^^ . " MODS" . . . . .